{"id":"https://openalex.org/W2892907232","doi":"https://doi.org/10.1016/j.ejpb.2018.09.027","title":"Rats can predict aversiveness of Active Pharmaceutical Ingredients","display_name":"Rats can predict aversiveness of Active Pharmaceutical Ingredients","alternate_titles":[],"publication_year":2018,"publication_date":"2018-09-27","ids":{"openalex":"https://openalex.org/W2892907232","doi":"https://doi.org/10.1016/j.ejpb.2018.09.027","mag":"2892907232","pmid":"https://pubmed.ncbi.nlm.nih.gov/30267837"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejpb.2018.09.027","doi":"https://doi.org/10.1016/j.ejpb.2018.09.027","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejpb.2018.09.027","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0939641118304636/pdf","source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2892907232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0939641118304636/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016526390","display_name":"Jessica Soto","orcid":"https://orcid.org/0000-0001-8961-9106","observed_orcids":["https://orcid.org/0000-0001-8961-9106"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["CH","GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jessica Soto","raw_affiliation_strings":["Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom; Novartis Pharma AG, Basel, Switzerland","Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom; Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066182911","display_name":"Alexander Keeley","orcid":"https://orcid.org/0000-0002-0048-5314","observed_orcids":["https://orcid.org/0000-0002-0048-5314"]},"institutions":[{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander Keeley","raw_affiliation_strings":["Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021035591","display_name":"Alison Veronica Keating","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alison V. Keating","raw_affiliation_strings":["Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022355905","display_name":"Abeer H. A. Mohamed-Ahmed","orcid":"https://orcid.org/0000-0002-0442-0956","observed_orcids":["https://orcid.org/0000-0002-0442-0956"]},"institutions":[{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Abeer H.A. Mohamed-Ahmed","raw_affiliation_strings":["Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057981609","display_name":"Yucheng Sheng","orcid":"https://orcid.org/0000-0003-1460-5070","observed_orcids":["https://orcid.org/0000-0003-1460-5070"]},"institutions":[{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yucheng Sheng","raw_affiliation_strings":["Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011157716","display_name":"Gesine Winzenburg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gesine Winzenburg","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007439491","display_name":"Roy Turner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roy Turner","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088104255","display_name":"Sabine Desset-Br\u00e8thes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sabine Desset-Br\u00e8thes","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074277071","display_name":"Mine Orlu","orcid":"https://orcid.org/0000-0002-2047-5025","observed_orcids":["https://orcid.org/0000-0002-2047-5025"]},"institutions":[{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mine Orlu","raw_affiliation_strings":["Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023161166","display_name":"Catherine Tuleu","orcid":"https://orcid.org/0000-0001-8384-357X","observed_orcids":["https://orcid.org/0000-0001-8384-357X"]},"institutions":[{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Catherine Tuleu","raw_affiliation_strings":["Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom. Electronic address: c.tuleu@ucl.ac.uk","Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom. Electronic address: c.tuleu@ucl.ac.uk","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]},{"raw_affiliation_string":"Department of Pharmaceutics, UCL School of Pharmacy, 29/39 Brunswick Square, WC1N 1AX London, United Kingdom","institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5023161166"],"corresponding_institution_ids":["https://openalex.org/I4405283614","https://openalex.org/I45129253"],"apc_list":{"value":4210,"currency":"USD","value_usd":4210},"apc_paid":{"value":2819,"currency":"EUR","value_usd":3040},"fwci":3.183,"has_fulltext":true,"cited_by_count":32,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90808943,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"133","issue":null,"first_page":"77","last_page":"84"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11584","display_name":"Biochemical Analysis and Sensing Techniques","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11584","display_name":"Biochemical Analysis and Sensing Techniques","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.08699999749660492,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12114","display_name":"Sensory Analysis and Statistical Methods","score":0.02459999918937683,"subfield":{"id":"https://openalex.org/subfields/1106","display_name":"Food Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.8759999871253967},{"id":"https://openalex.org/keywords/taste-aversion","display_name":"taste aversion","score":0.8080000281333923},{"id":"https://openalex.org/keywords/bitter-taste","display_name":"bitter taste","score":0.7329999804496765},{"id":"https://openalex.org/keywords/taste-assessment","display_name":"taste assessment","score":0.6179999709129333},{"id":"https://openalex.org/keywords/taste-masking","display_name":"taste masking","score":0.5649999976158142},{"id":"https://openalex.org/keywords/quinine-hydrochloride","display_name":"quinine hydrochloride","score":0.7450000047683716},{"id":"https://openalex.org/keywords/6-n-propylthiouracil","display_name":"6-n-propylthiouracil","score":0.9800000190734863},{"id":"https://openalex.org/keywords/sildenafil-citrate","display_name":"sildenafil citrate","score":0.8320000171661377},{"id":"https://openalex.org/keywords/diclofenac-sodium","display_name":"diclofenac sodium","score":0.9789999723434448},{"id":"https://openalex.org/keywords/ranitidine-hydrochloride","display_name":"ranitidine hydrochloride","score":0.9739999771118164},{"id":"https://openalex.org/keywords/caffeine-citrate","display_name":"caffeine citrate","score":0.9869999885559082},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/telbivudine","display_name":"telbivudine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/paracetamol","display_name":"paracetamol","score":1.0}],"concepts":[{"id":"https://openalex.org/C8868529","wikidata":"https://www.wikidata.org/wiki/Q124794","display_name":"Taste","level":2,"score":0.6276688575744629},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.4940634071826935},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4643229842185974},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42643284797668457},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31134939193725586},{"id":"https://openalex.org/C31903555","wikidata":"https://www.wikidata.org/wiki/Q1637030","display_name":"Food science","level":1,"score":0.21938487887382507}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013649","descriptor_name":"Taste","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.ejpb.2018.09.027","doi":"https://doi.org/10.1016/j.ejpb.2018.09.027","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejpb.2018.09.027","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0939641118304636/pdf","source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},{"id":"pmid:30267837","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30267837","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V","raw_type":"Journal Article"},{"id":"pmh:oai:researchonline.lshtm.ac.uk:4657818","doi":null,"is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejpb.2018.09.027","pdf_url":null,"source":{"id":"https://openalex.org/S4306402527","display_name":"LSHTM Research Online (London School of Hygiene and Tropical Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210089966","host_organization_name":"London School of Hygiene & Tropical Medicine","host_organization_lineage":["https://openalex.org/I4210089966"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10057151","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/10057151/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics (2018) (In press).","raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10064357","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10064357/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics , 133 pp. 77-84. (2018)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.ejpb.2018.09.027","doi":"https://doi.org/10.1016/j.ejpb.2018.09.027","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejpb.2018.09.027","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0939641118304636/pdf","source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2882476434","display_name":"From Targeted Therapeutics to Next-Generation Medicines","funder_award_id":"EP/I01375X/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G3160298724","display_name":null,"funder_award_id":"1487640","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G6354898897","display_name":null,"funder_award_id":"EP/I01375X/1","funder_id":"https://openalex.org/F4320307770","funder_display_name":"AstraZeneca"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"},{"id":"https://openalex.org/F4320335087","display_name":"Innovate UK","ror":"https://ror.org/05ar5fy68"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2892907232.pdf","grobid_xml":"https://content.openalex.org/works/W2892907232.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W150386553","https://openalex.org/W1984288077","https://openalex.org/W1986875887","https://openalex.org/W1986962276","https://openalex.org/W2000539161","https://openalex.org/W2024662646","https://openalex.org/W2025142432","https://openalex.org/W2035472869","https://openalex.org/W2046663824","https://openalex.org/W2049372650","https://openalex.org/W2060313906","https://openalex.org/W2070629878","https://openalex.org/W2074927293","https://openalex.org/W2089973765","https://openalex.org/W2123318097","https://openalex.org/W2147945544","https://openalex.org/W2156258968","https://openalex.org/W2159030941","https://openalex.org/W2162239028","https://openalex.org/W2253183879","https://openalex.org/W2406231440","https://openalex.org/W2494551919"],"related_works":["https://openalex.org/W2747640521","https://openalex.org/W1984288077","https://openalex.org/W157655059","https://openalex.org/W3199579764","https://openalex.org/W2511887958","https://openalex.org/W2156258968","https://openalex.org/W2406231440","https://openalex.org/W3012340263","https://openalex.org/W2602490433"],"abstract_inverted_index":{"Taste":[0],"is":[1,25,46],"crucial":[2],"for":[3,91,198,211,222],"patient":[4],"acceptability":[5],"and":[6,52,132,151,182,195,213],"compliance":[7],"with":[8,13,140,155],"prescribed":[9],"medicines,":[10],"in":[11,30,142,239],"particular":[12],"pediatric":[14],"patients.":[15],"Evaluating":[16],"the":[17,65,77,80,103,147,156,160,167,189],"taste":[18,54,83,100,104,144,153,236,245],"of":[19,64,71,79,93,106,115,158,166,201,234],"new":[20],"active":[21],"pharmaceutical":[22],"ingredients":[23],"(APIs)":[24],"therefore":[26],"essential":[27],"to":[28,40,50,75,111,163,230],"put":[29],"place":[31],"adequate":[32],"taste-masking":[33],"techniques,":[34],"if":[35],"needed,":[36],"which":[37],"will":[38],"lead":[39],"acceptable":[41],"palatable":[42],"formulations.":[43],"Thus,":[44],"there":[45,171],"an":[47],"urgent":[48],"need":[49],"develop":[51],"optimize":[53],"assessment":[55,92,145,200],"methods":[56],"that":[57,96,241],"could":[58,97],"be":[59],"used":[60],"at":[61,136],"different":[62,113,137],"stages":[63],"drug":[66],"development":[67],"process.":[68],"The":[69],"aim":[70],"this":[72],"study":[73],"was":[74,134,172,208,219,227],"investigate":[76],"suitability":[78],"rat":[81,148],"brief-access":[82],"aversion":[84],"(BATA)":[85],"model":[86,150,191],"as":[87,192],"a":[88,173,193,232],"screening":[89],"tool":[90,197],"APIs":[94,109],"aversiveness":[95],"predict":[98,243],"human":[99,152,244],"responses.":[101],"Presently,":[102],"intensity":[105,117,237],"nine":[107],"marketed":[108],"known":[110],"have":[112],"levels":[114],"bitter":[116],"(quinine":[118],"hydrochloride":[119],"dihydrate,":[120],"6-n-propylthiouracil,":[121],"sildenafil":[122],"citrate,":[123,129],"diclofenac":[124],"sodium,":[125],"ranitidine":[126],"hydrochloride,":[127],"caffeine":[128],"isoniazid,":[130],"telbivudine":[131],"paracetamol)":[133],"investigated":[135],"overlapping":[138],"concentrations":[139,162],"two":[141],"vivo":[143],"methods:":[146],"BATA":[149,190],"panels":[154],"intention":[157],"determining":[159],"drugs\u2019":[161],"produce":[164],"half":[165],"maximal":[168],"rating.":[169],"Overall":[170],"strong":[174],"correlation":[175,187],"(R2":[176],"=":[177],"0.896)":[178],"between":[179],"rats":[180,240],"IC50":[181],"humans":[183],"EC50":[184],"values.":[185],"This":[186],"verifies":[188],"rapid":[194],"reliable":[196],"quantitative":[199],"API":[202],"aversiveness.":[203],"A":[204],"comparable":[205],"ranking":[206],"order":[207],"obtained":[209],"mainly":[210],"high":[212],"medium":[214],"aversive":[215,224],"compounds,":[216],"whereas":[217],"it":[218],"less":[220],"aligned":[221],"weakly":[223],"compounds.":[225],"It":[226],"nonetheless":[228],"possible":[229],"propose":[231],"classification":[233],"poor":[235],"determined":[238],"would":[242],"tolerability.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2892907232","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-10-05T00:00:00"}
